- Report
- March 2024
- 194 Pages
Global
From €3208EUR$3,374USD£2,751GBP
€3564EUR$3,749USD£3,057GBP
- Report
- January 2022
- 200 Pages
Global
From €7130EUR$7,500USD£6,116GBP
- Report
- July 2022
- 120 Pages
Global
From €2377EUR$2,500USD£2,039GBP
- Report
- August 2023
- 81 Pages
Global
From €3500EUR$3,944USD£3,107GBP
Malabsorption Syndrome Drugs are a type of Gastrointestinal Drugs used to treat malabsorption syndrome, a condition in which the body is unable to absorb nutrients from food. These drugs are used to replace the missing nutrients and help the body absorb them. Commonly used drugs include pancreatic enzymes, bile acid sequestrants, and probiotics. Pancreatic enzymes are used to replace the enzymes that the pancreas is unable to produce, while bile acid sequestrants are used to bind bile acids and prevent them from being reabsorbed. Probiotics are used to restore the balance of beneficial bacteria in the gut.
Some companies in the Malabsorption Syndrome Drug market include AbbVie, Allergan, AstraZeneca, Bayer, GlaxoSmithKline, Merck, Novartis, Pfizer, and Takeda. Show Less Read more